FRZB and depressive symptom measurement: Sfrp3 is an essential mediator of some antidepressant actions in animal models and polymorphisms in the human gene are significantly associated with partial antidepressant responses in patients, which suggest that manipulation of SFRP3 action may represent a novel therapeutic approach to treat depression [40].